Apoptosis Signal-Regulating Kinase 1 Is Involved in Brain-Derived Neurotrophic Factor (BDNF)-Enhanced Cell Motility and Matrix Metalloproteinase 1 Expression in Human Chondrosarcoma Cells

International Journal of Molecular Sciences

Chih-Yang Lin¹  Sunny Li-Yun Chang¹  Yi-Chin Fong²  Chin-Jung Hsu² 

[1] Graduate Institute of Basic Medical Science, China Medical University, Taichung 404, Taiwan; E-Mails:;School of Chinese Medicine, China Medical University, Taichung 404, Taiwan; E-Mails:

关键词: BDNF;    TrkB;    ASK1;    MMP-1;    chondrosarcoma;   

DOI  :  10.3390/ijms140815459

来源: mdpi

【 摘 要 】

Chondrosarcoma is the primary malignancy of bone that is characterized by a potent capacity to invade locally and cause distant metastasis, and is therefore associated with poor prognoses. Chondrosarcoma further shows a predilection for metastasis to the lungs. The brain-derived neurotrophic factor (BDNF) is a small molecule in the neurotrophin family of growth factors that is associated with the disease status and outcome of cancers. However, the effect of BDNF on cell motility in human chondrosarcoma cells is mostly unknown. Here, we found that human chondrosarcoma cell lines had significantly higher cell motility and BDNF expression compared to normal chondrocytes. We also found that BDNF increased cell motility and expression of matrix metalloproteinase-1 (MMP-1) in human chondrosarcoma cells. BDNF-mediated cell motility and MMP-1 up-regulation were attenuated by Trk inhibitor (K252a), ASK1 inhibitor (thioredoxin), JNK inhibitor (SP600125), and p38 inhibitor (SB203580). Furthermore, BDNF also promoted Sp1 activation. Our results indicate that BDNF enhances the migration and invasion activity of chondrosarcoma cells by increasing MMP-1 expression through a signal transduction pathway that involves the TrkB receptor, ASK1, JNK/p38, and Sp1. BDNF thus represents a promising new target for treating chondrosarcoma metastasis.

【 授权许可】

CC BY   
© 2013 by the authors; licensee MDPI, Basel, Switzerland